News

Net Loss of Vista Pharmaceuticals reported to Rs 5.86 crore in the quarter ended March 2026 as against net loss of Rs 1.50 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 as against Rs 3.23 crore during the previous quarter ended March 2025.For the full year,net loss reported to Rs 12.06 crore in the year ended March 2026 as against net loss of Rs 4.65 crore during the previous year ended March 2025. Sales declined 46.38% to Rs 5.40 crore in the year ended March 2026 as against Rs 10.07 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales03.23 -100 5.4010.07 -46 OPM %0-28.48 --270.74-40.02 - PBDT-7.58-0.89 -752 -15.40-4.55 -238 PBT-7.77-1.07 -626 -16.15-5.29 -205 NP-5.86-1.50 -291 -12.06-4.65 -159 Powered by Capital Market - Live News

Vista Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 May 2026.

Vista Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live News

Vista Pharmaceuticals has revised the meeting of the Board of Directors which was scheduled to be held on 23 February 2026. The meeting will now be held on 13 February 2026.Powered by Capital Market - Live News

Vista Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live News